Cerus Corp (CERS) stock

CERSNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 2, 2026Score 6/3023% below fair value

$1.99+0.05 (+2.32%)

Close on Nov 13, 2026Market cap $400.03MP/E –Yield –

Cerus price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Cerus's price to sales ratio was 1.7× on Nov 11, 2026, against 11.7× a year earlier. Over the last 5 years it ranged from 1.5× to 21.2×, with a median of 11.6×.

Price to Sales Ratio at the end of each year

Period	Period end	Value	Change (pts)
2026	Nov 11, 2026	1.7×	−9.4
2019	Apr 30, 2019	11.0×	+0.5
2018	Dec 31, 2018	10.6×	+1.0
2017	Dec 29, 2017	9.5×	−2.4
2016	Dec 30, 2016	11.9×	−5.1
2015	Dec 31, 2015	17.0×	+4.2
2014	Dec 31, 2014	12.8×	+2.6
2013	Dec 31, 2013	10.2×	+5.5
2012	Dec 31, 2012	4.7×	−0.2
2011	Dec 30, 2011	4.8×	+0.1
2010	Dec 31, 2010	4.8×	–